XML 45 R32.htm IDEA: XBRL DOCUMENT v3.19.2
Revenues - Revenues by Disaggregated Category (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 28, 2019
Jun. 29, 2018
Jun. 28, 2019
Jun. 29, 2018
Disaggregation of Revenue [Line Items]        
Total revenues $ 240,275 $ 186,108 $ 455,762 $ 399,827
Collaborative Arrangement with Ipsen        
Disaggregation of Revenue [Line Items]        
Total revenues 22,249 34,043 $ 44,117 87,852
GSK | Collaborative Arrangement with Ipsen        
Disaggregation of Revenue [Line Items]        
Percent of royalty on net sale     3.00%  
Net product revenues        
Disaggregation of Revenue [Line Items]        
Total revenues 193,675 145,836 $ 373,256 280,108
Gross product revenues        
Disaggregation of Revenue [Line Items]        
Total revenues 240,418 172,646 464,168 332,082
Discounts and allowances        
Disaggregation of Revenue [Line Items]        
Total revenues 46,743 26,810 90,912 51,974
Total collaboration revenues        
Disaggregation of Revenue [Line Items]        
Total revenues 46,600 40,272 82,506 119,719
License revenues        
Disaggregation of Revenue [Line Items]        
Total revenues 36,393 31,908 60,902 100,938
Research and development services revenues        
Disaggregation of Revenue [Line Items]        
Total revenues 10,898 6,805 22,826 16,904
Other collaboration revenues        
Disaggregation of Revenue [Line Items]        
Total revenues $ (691) $ 1,559 $ (1,222) $ 1,877